#19. IDO predicts death in NEN
Prof. Joerg Schefold of the Bern University Hospital, Switzerland talks about his latest publication in Neuroendocrinology - 'Increased activity of the immunoregulatory enzyme Indoleamine-2,3-dioxygenase (IDO) with consecutive tryptophan depletion predicts death in patients with neuroendocrine neoplasia"